EUVIMEDEUVIMED entdecken
Crossref

Treatment of post-transplant lymphoproliferative disorders in kidney transplant recipients: a single-center retrospective analysis

Futoshi Yoshino, Daisuke Kaji, Otoya Watanabe, Kyosuke Yamaguchi, Kosei Kageyama, Yuki Taya, Aya Nishida, Kazuya Ishiwata, Shinsuke Takagi, Hisashi Yamamoto, Yuki Asano-Mori, Naoyuki Uchida und 2 weitere

International Journal of Hematology · 2025

DOI: 10.1007/s12185-025-04039-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Hematology, 2025. Verfasst von Futoshi Yoshino und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Toranomon Hospital, 2-2-2, Toranomon, Minato-Ward, Tokyo, 105-8470, Japan. Hauptthemen laut MEDLINE: Kidney Transplantation, Lymphoproliferative Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post-transplant lymphoproliferative disorder (PTLD) is a significant complication of immunosuppression after kidney transplantation and has no established standard therapy. Achieving favorable treatment outcomes and preserving renal function in patients with PTLD remains challenging, particularly when the central nervous system (CNS) is involved. Here we describe our experience with 8 patients who developed PTLD after kidney transplantation at our institution. Diffuse large B-cell lymphoma was the most common histological subtype, observed in 5 patients (62.5%). Epstein-Barr Virus infections were observed in 7 patients (87.5%), CNS involvement in 5 patients (62.5%) and gastrointestinal tract involvement in 3 patients (37.5%). With a median follow-up of 55.3 months, the 4-year overall survival rate was 72.9%. Seven patients (87.5%) achieved complete remission (CR), and 5 maintained CR as of the last follow-up visit. In the CNS involvement group, patients treated with aggressive chemotherapy died of sepsis, and those treated with a combination of rituximab, whole-brain radiation therapy, and reduction of immunosuppression achieved long-term progression-free survival without reinstitution of dialysis or neurological toxicity. The clinical courses of these 8 kidney transplant recipients who developed PTLD, most of whom had CNS involvement, suggest that long-term remission may be achievable without systemic chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationLymphoproliferative DisordersHumansMaleRetrospective StudiesMiddle AgedFemaleAdultEpstein-Barr Virus InfectionsRituximabAgedLymphoma, Large B-Cell, Diffuse

Stichwörter der Autor:innen

Central nervous systemKidney transplantLymphomaPost-transplant lymphoproliferative disorderRituximab

Substanzen

Rituximab

Autor:innen und Institutionen

  • Department of Hematology, Toranomon Hospital, 2-2-2, Toranomon, Minato-Ward, Tokyo, 105-8470, Japan.
  • Department of Hematology, Toranomon Hospital, 2-2-2, Toranomon, Minato-Ward, Tokyo, 105-8470, Japan. kaji613@toranomon.gr.jp.
  • Department of Transfusion and Cellular Therapy, Toranomon Hospital, Tokyo, Japan. kaji613@toranomon.gr.jp.
  • Center for Cellular Therapy, Toranomon Hospital, Tokyo, Japan. kaji613@toranomon.gr.jp.
  • Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan.
  • Department of Transfusion and Cellular Therapy, Toranomon Hospital, Tokyo, Japan.

Zitieren

APA

Yoshino, F., Kaji, D., Watanabe, O., Yamaguchi, K., Kageyama, K., Taya, Y., Nishida, A., Ishiwata, K., Takagi, S., Yamamoto, H., Asano-Mori, Y., Uchida, N., Wake, A., & Yamamoto, G. (2025). Treatment of post-transplant lymphoproliferative disorders in kidney transplant recipients: a single-center retrospective analysis. International Journal of Hematology. https://doi.org/10.1007/s12185-025-04039-4

Vancouver

Yoshino F, Kaji D, Watanabe O, Yamaguchi K, Kageyama K, Taya Y, et al. Treatment of post-transplant lymphoproliferative disorders in kidney transplant recipients: a single-center retrospective analysis. International Journal of Hematology. 2025. doi:10.1007/s12185-025-04039-4

BibTeX
@article{Yoshino2025,
  author = {Yoshino, Futoshi and Kaji, Daisuke and Watanabe, Otoya and Yamaguchi, Kyosuke and Kageyama, Kosei and Taya, Yuki and Nishida, Aya and Ishiwata, Kazuya and Takagi, Shinsuke and Yamamoto, Hisashi and Asano-Mori, Yuki and Uchida, Naoyuki and Wake, Atsushi and Yamamoto, Go},
  title = {Treatment of post-transplant lymphoproliferative disorders in kidney transplant recipients: a single-center retrospective analysis},
  journal = {International Journal of Hematology},
  year = {2025},
  doi = {10.1007/s12185-025-04039-4}
}
Kostenlos starten →